MyCardia

N/A

Report date: 2025/03/20 15:58:33

Base Information

Drug NameMyCardia
Drug Alias Nameinduced pluripotent stem cell therapy (Avery Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac myocyte stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsMyocardial InfarctionHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesAvery Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A